Joel Morales has served as Alvotech’s Chief Financial Officer since February 2020 after holding the same role for affiliated company Alvogen since 2017. Prior to joining Alvotech he held various positions of increasing responsibility with Endo International plc., with his last position as Senior Vice President of the Generics Business Segment and Global Finance Operations. Prior to that, Joel spent ten years working for large multinational pharmaceutical companies, including Merck and Schering Plough.

Joel is a licensed certified public accountant in the State of New Jersey and has a Bachelor of Science degree in accounting from Rutgers University.